Invention Grant
- Patent Title: LAT adapter molecule for enhanced T-cell signaling and method of use
-
Application No.: US14329736Application Date: 2014-07-11
-
Publication No.: US09649339B2Publication Date: 2017-05-16
- Inventor: Lawrence E. Samelson , Lakshmi Balagopalan
- Applicant: The United States of America, as represented by the Secretary, Department of Health & Human Services
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
- Current Assignee Address: US DC Washington
- Agency: Locke Lord LLP
- Agent Gabriel J. McCool
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K35/17 ; C07K14/47 ; G01N33/566 ; A61K38/00

Abstract:
LAT (Linker for Activation of T-cells) is a protein involved in signaling through the T-cell receptor (TCR). The invention provides a LAT protein including mutations at ubiquitylation sites that result in an increase in stability of LAT in stimulated and unstimulated cells, and enhanced signaling through the TCR. The invention further provides use for a LAT protein including mutations at ubiquitylation sites for therapeutic and laboratory methods.
Public/Granted literature
- US20150202230A1 LAT ADAPTER MOLECULE FOR ENHANCED T-CELL SIGNALING AND METHOD OF USE Public/Granted day:2015-07-23
Information query